News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

BioSpace News - All
BIO2017: Biotech Dealmaking Will Be Robust in 2017, But Remain Below 2015 Highs 6/22/2017
BIO2017: BIO Urges Biotech Leaders to Get Active on Legislation 6/22/2017
12 Careers for Life Scientists Outside of the Lab 6/22/2017
3 Biotech Stocks That Look Like Apple (AAPL) Did in the 1980s 6/22/2017
Insiders Just Bought $234 Million Worth of These Pharma Stocks 6/22/2017
Seattle Genetics (SGEN) Takes Another Hit as the FDA Slaps Hold on IND for Vadastuximab Talirine 6/22/2017
Amgen (AMGN) Goes on the Defensive When Critics Call Its Pipeline a Dud 6/22/2017
15 In-Demand Life Science Jobs in Northern California 6/22/2017
OvaScience (OVAS) Slashes 50% of Workforce, Replaces CEO 6/22/2017
Repare Therapeutics Bursts From Stealth Mode With $68 Million and a Team Packed With Industry Alums 6/22/2017
Genentech (RHHBY) Wins No. 1 Top Spot as The Ideal Employer in Life Sciences 6/22/2017
Employee in Critical Condition After Shooting at San Diego Biotech Phamatech 6/21/2017
More Deaths Lead Seattle Genetics (SGEN) to Discontinue Phase III Leukemia Study 6/21/2017
Clovis Oncology (CLVS) Stock Soars as Ovarian Cancer Trial Dazzles 6/21/2017
BIO2017: BIO Leaders Honor Memory of Genzyme’s Henri Termeer 6/21/2017
BIO2017: Ann Romney Shares Journey Through MS Treatments, Founding of Neurological Research Center 6/21/2017
Novartis AG (NVS) Rejects Trump's Proposition to Create More U.S Jobs 6/21/2017
PAREXEL (PRXL) Sold to Investment Firm in $5 Billion Deal 6/21/2017
Cambridge Biotech Startup Rubius Banks $120 Million, Hopes to Hire 60 New Staffers 6/21/2017
Massachusetts Biotech Startup Sigilon Launches With $23.5 Million 6/21/2017
3 Pharma Stocks Billionaire Izzy Englander Bought Recently 6/21/2017
Tiny New York Biotech With Ties To Massachusetts, Syntimmune, Gets A $50 Million Boost 6/21/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research 6/21/2017
A Look at the 5 Most Profitable Biopharma Companies 6/21/2017
Biogen (BIIB) Brings Ex-Shire (SHPG) Exec Into C-Suite 6/21/2017
Novartis AG (NVS)'s Next-Generation Eye Drug Works With Fewer Injections Than Rivals 6/21/2017
BIO2017: Former UK Prime Minister Cameron Calls for More Alzheimer’s Research 6/21/2017
Life Sciences Professionals Name Top 30 Ideal Employers 6/20/2017
Governor Launches $500 Million Initiative to Keep Massachusetts' Biotech World Booming 6/20/2017
Bay Area Tech Titan Sean Parker Reaches Out to Unheard-Of Biotech to Confront Immunotherapy 6/20/2017
Warning: These Could be the Top 3 Most Overrated Biotech Stocks 6/20/2017
Inovio Pharma (INO) CEO Forging Multiple Deals, Expanding Pipeline and Adding 100 New Jobs 6/20/2017
BIO2017: After IPO, Full Speed Ahead for San Diego’s Tocagen 6/20/2017
Why This Tiny Massachusetts Biotech Could be a New M&A Target for Drug Giants Like Gilead (GILD) and Celgene (CELG) 6/20/2017
Bayer (BAY) Puts Down More Roots in Massachusetts With New Life Science Center 6/20/2017
Faltering Enumeral Biomedical (ENUM) Cuts R&D Staff, Alters Executive Compensation Deal 6/20/2017
New Data Reveals This New York Biotech's Pipeline Could be a Game Changer 6/19/2017
Checkmate Notches $27 Million and Taps Ex-FORUM Pharma Exec as COO 6/19/2017
Roche (RHHBY)'s Former New Jersey Site to Become a Life Sciences Campus 6/19/2017
Sonar Products, Stratus Pharma Ordered to Cease Operations 6/16/2017
Why Drug Giants Like Merck & Co. (MRK) and AstraZeneca PLC (AZN) Scientists are Looking in the Toilet for New Cancer Treatments 6/16/2017
Why This Overlooked New Jersey Biotech Could be an Orphan Underdog 6/16/2017
Epizyme (EPZM) Falls as Investors Take in Disappointing Phase II Data 6/16/2017
What Biogen (BIIB) CFO's Departure Means for Company's M&A Strategy 6/16/2017
New Biotech Incubator Just Opened Up in the Big Apple—With Room for 25 Startups 6/16/2017
Gilead (GILD), Sanofi (SNY) Reportedly Bidding on This $10 Billion Massachusetts Biotech 6/16/2017
Why This Bay Area Biotech Could Be the Best-in-Breed for 2017 6/16/2017
After Bagging Patheon (PTHN) for $7.2 Billion, This Could be Thermo Fisher Scientific (TMO)'s New Target 6/16/2017
Google (GOOG)'s Verily (GOOGL) and Novartis AG (NVS) Jump Into Medicxi's $300 Million Life Science Investment Fund 6/15/2017
UK Charity to Use $638 Million Cash From Merck & Co. (MRK)'s Blockbuster Keytruda to Back R&D 6/15/2017
When Inspiring a Passion for STEM Begins After School 6/15/2017
Up and Coming Scientist Gets Funding for CAR-T Startup CARMA Therapeutics 6/15/2017
AstraZeneca PLC (AZN) CEO Warns of More Setbacks, Admits Company is Still Vulnerable to a Takeover 6/15/2017
Sanofi (SNY) Commits $673 Million in Biologics 6/14/2017
Deaths Force Merck & Co. (MRK) to Halt Enrollment for Blood Cancer Studies 6/14/2017
Why Celgene (CELG) Gets No R-E-S-P-E-C-T, But Should 6/14/2017
Meet the Scientist Finding Success at Other Biotechs Working on Old Pfizer (PFE) Compounds 6/14/2017
Hiring Underway at PsiOxus' New Facility in Philadelphia 6/14/2017
Massachusetts Biotech iSpecimen Launches Amazon (AMZN)-Like Marketplace for Scientists 6/14/2017
Alexion (ALXN) Poaches Biogen (BIIB)'s Longtime CFO 6/14/2017
Landmark Ruling: Amgen (AMGN) Loses Bid to Delay Biosimilars 6/13/2017
Why This Tiny New Jersey Biotech Looks Like Oracle in 1986 6/13/2017
SoCal's Regulus (RGLS) Sinks After AstraZeneca PLC (AZN) Bails on Lead NASH Drug 6/13/2017
What Biogen (BIIB) Wants in Return for Financial Assistance of Its $750,000 a Year Drug 6/13/2017
Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen (AMGN)'s Neulasta 6/13/2017
It’s Time for Physicians to Embrace Clinical Genomics 6/13/2017
Meet 7 Bay Area Scientists Changing the Face of Biotech 6/13/2017
Meet GammaDelta Therapeutics's CEO—The Scientist Who Helped GlaxoSmithKline (GSK) Launch 7 Cancer Drugs 6/13/2017
Sanofi (SNY)'s Rumored Buyout Target Flexion (FLXN) Shows Off Mid-Stage Osteoarthritis Data 6/12/2017
Bristol-Myers Squibb (BMY) Asks for Patience as Takeover Chatter Reemerges Post-ASCO 6/12/2017
Hundreds of Patient Deaths Linked to Roche (RHHBY)'s RA Drug Actemra 6/12/2017
The Single Best Hep C Drug Stock to Buy in 2017—Hint, It's Not Gilead (GILD) 6/12/2017
Johnson & Johnson (JNJ) Poaches Merck & Co. (MRK) Exec to Run Pharma R&D 6/12/2017
Effective Immediately: Bristol-Myers Squibb (BMY) Exec to Take the Reins at Kleo 6/12/2017
2 Biotechs Insiders Just Bought $70 Million Worth of Stock In 6/12/2017
NantHealth (NH)'s Patrick Soon-Shiong Expands His Empire With Plans to Open a World-Class Cancer Center This Summer 6/12/2017
First Time Ever: FDA Asks Endo Pharma (ENDP) to Stop Selling Opana ER Amid Opioid Crisis 6/9/2017
16 Questions Top Pharma Applicants Should Ask During the Job Interview 6/9/2017
Smart Biotech Careers for Job Seekers With No PhD 6/9/2017
Booming Glenmark Pharma Could File One NDA Each Year For 10 Years 6/9/2017
Investment Group Just Paid $605 Million for This Bay Area Pharma 6/9/2017
NewLink Genetics (NLNK) Stock Plunges After Genentech (RHHBY) Bails on $1 Billion+ IDO Deal 6/9/2017
Top 10 Life Science Job Trends in 2017 6/9/2017
Tiny Bay Area Biotech Wants to Rattle the Billion-Dollar Injectable Drug Markets With a Single Pill 6/8/2017
Bristol-Myers Squibb (BMY) Loses $4.3 Billion in Market Value After ASCO Update 6/8/2017
Why This Seattle Biotech's Stock Has More Than Doubled in 8 Months 6/8/2017
Loxo Oncology (LOXO) Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It 6/8/2017
The 1 Pharma Stock That Feels Like Microsoft in 1986 6/8/2017
This Small Massachusetts Biotech Soared to a 20-Month High on Its Celgene (CELG)-Partnered Trial 6/8/2017
Bomb Scare Leads to Evacuation at Pfizer (PFE) Plant 6/7/2017
Debt-Ridden Valeant (VRX) Nears Sale of Its $2 Billion Eye Care Biz Bausch & Lomb 6/7/2017
AstraZeneca PLC (AZN) Eases Its Migraine With $302 Million Sale 6/7/2017
Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co. (MRK) 6/7/2017
PE Firms Take Out New York's AMRI (AMRI) for $922 Million Cash 6/7/2017
Unknown Nanjing Legend Emerges as a CAR-T Phenom at ASCO 6/7/2017
Bay Area GRAIL's Billion Gamble on the Perfect Cancer Test 6/7/2017
How Much is Too Much to Pay for Newly Approved Drugs? 6/7/2017
Novan Lays Off 20% of Workforce, Switches Up C-Suite 6/6/2017
Acorda (ACOR) Jumps as Parkinson’s Drug Performs Well in Late-Stage Study 6/6/2017
Perrigo (PRGO) CEO to Retire After Only 14 Months on the Job 6/6/2017
Genentech (RHHBY)’s Perjeta-Based Adjuvant Breast Cancer Care Shows Minor Improvement, Puma Biotech (PBYI) Shares Jump 6/6/2017
New Immuno-Onco Deal With Merck KGaA (MKGAF.PK) Could Make This UK Biotech a $1 Billion Company 6/6/2017
Cambridge's 30-Person Cure Forward to Dissolve This Week 6/6/2017
2 Small Biotechs Whose ASCO Presentations Could Kick Stocks Higher 6/6/2017
7 Biotechs and Pharmas That Have the Potential to Double (or More) 6/6/2017
Philadelphia Drugmaker Iroko Pharma Pink Slips Another 122 Employees 6/5/2017
How to Follow Up After a Career Event 6/5/2017
Investors Sigh With Relief as bluebird bio (BLUE), Celgene (CELG)'s CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free 6/5/2017
Down but Not Out, Juno (JUNO) Fights Back with Positive CAR-T Results in its JCAR017 Program 6/5/2017
New Alexion (ALXN) CEO Brings Two Former Baxalta (BXLT) Pals and One Pfizer (PFE) Alum Into the C-Suite 6/5/2017
Stock Tanks as Endocyte (ECYT) Cuts 40% of Workforce, Slashes 2 Clinical Programs 6/5/2017
Elated Bristol-Myers Squibb (BMY), Seattle Genetics (SGEN) Rewrite Agreement to Push Promising Drug Combo Into Phase III 6/5/2017
Spectacular Data Posted for Novartis AG (NVS)'s Next Generation CAR-T Drug 6/2/2017
Why Pfizer (PFE), AstraZeneca PLC (AZN) and Clovis Oncology (CLVS) Aren’t Interested in Tesaro (TSRO) 6/2/2017
10 Biotechs Awaiting FDA Decisions in June 6/2/2017
Novartis AG (NVS) Lays Out R&D Game Plan at Meet and Greet With 30 Execs in Boston 6/2/2017
Meet the 31-Year Old Worth $3 Billion Helping Drug Companies Like Bristol-Myers Squibb (BMY) and Pfizer (PFE) Market in Doctors' Offices 6/2/2017
$8 Billion+ Tesaro (TSRO) is Exploring a Sale But No Serious Suitors are Lining Up Just Yet 6/2/2017
Founding CEO of Editas Medicine (EDIT) Lands New Gig at Top Biotech VC Firm 6/2/2017
Bias Intuition and Life Science Job Recruiting: the Recruiter 6/2/2017
Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic 6/1/2017
Investors Relieved as Novartis AG (NVS) CEO Seeks Only $5 Billion Bolt-On Acquisitions, Not Huge M&As 6/1/2017
Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline 6/1/2017
A Look at Gilead (GILD)'s Possible New Drug Strategy 6/1/2017
CRISPR (CRSP), Editas Medicine (EDIT) and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing 6/1/2017
Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data 6/1/2017
Networking Tips for Career Events 5/31/2017
Vancouver’s Zymeworks to Hire an Additional 45 Employees by the End of 2017 5/31/2017
Struggling MannKind (MNKD) Replaces CEO 5/31/2017
Why This Tiny SoCal Biopharma Could be a Real Threat to Mylan (MYL) 5/31/2017
Investors Antsy as Novartis AG (NVS) Mulls Over Selling $50 Billion in Assets 5/31/2017
Why June Could be a Pivotal Month for These 2 Biotechs 5/31/2017
Bay Area Biotech Inks IBD Deal Worth $990 Million With Drug Giant Johnson & Johnson (JNJ) 5/31/2017
Aerie (AERI) Rockets as Eye Drug Wows in Key Phase III Study 5/30/2017
Cambridge Biotech Enumeral Biomedical (ENUM) Has Cash to Fund Its Operations Only Into Next Month 5/30/2017
Roche (RHHBY)'s New MS Drug Linked to Deadly Brain Infection 5/30/2017
Germany's Evotec AG (EVTG.F) Plans to Hire Scientists and Execs at New U.S. HQ 5/30/2017
Biogen (BIIB) Loses Yet Another Top Exec 5/30/2017
Recruiting Veterans for Life Science Jobs is a Focus at BIO 5/30/2017
26 Patients Dead After Replacing Controller for Abbott (ABT)'s HeartMate II Blood Pumps at Home 5/30/2017
Why Puma Biotech (PBYI) Could Get Acquired Between July to September of This Year 5/30/2017
New FDA Head Lifts Hiring Freeze, Takes Aim at the Next Martin Shkreli and Marathon Pharma 5/30/2017
How Much Juno (JUNO) Spent on Its Failed CAR-T Drug 5/30/2017
5 Big Pharmas Facing Catalysts in 2017 5/26/2017
Cannabis Jobs That Require a Life Science Background Are Booming 5/26/2017
Biocryst (BCRX) Stock Caught Fire After Reporting Positive Phase II HAE Data 5/26/2017
Jounce (JNCE)'s Number One Employee Rejoins Constellation Pharma as New CEO 5/26/2017
Journalist Sues FDA for Documents Related to Sarepta (SRPT)'s DMD Drug 5/26/2017
Top 5 Likable CEOs in Biotech and Pharma 5/26/2017
Alexion (ALXN): A Successful Migration of a Biopharma Corporate Data Center to the Cloud 5/25/2017
Novartis AG (NVS) to Lay Off 250 Nationwide, With 204 from New Jersey U.S. Headquarters 5/25/2017
Silicon Valley VCs Quietly Hiring Biotech Experts 5/25/2017
Here's What You Need to Know to Get a Clinical Research Job 5/25/2017
Arix Bioscience Gets in on Bay Area Cancer Biotech Harpoon's $45 Million Funding Round 5/25/2017
How Alexion (ALXN) is Making So Much Cash With a Drug That Treats Less Than 11,000 Patients 5/25/2017
3 Biopharma Stocks Billionaire Money Managers Unloaded Recently 5/25/2017
Puma Biotech (PBYI) Defies Odds, Wins FDA Backing for Breast Cancer Drug 5/25/2017
Massive FDA and NIH Cuts in Trump's Outlined Budget Plan 5/24/2017
Neurocrine (NBIX) Tanks as Tourette Syndrome Drug Flunks Mid-Stage Study 5/24/2017
Alexion (ALXN) Boss Shakes Up Executive Team, Head of R&D Retires, CFO and HR Exec Step Down 5/24/2017
Former Biogen (BIIB) Exec Launches Bain Capital’s First Life Sciences Fund With $750 Million 5/24/2017
These 3 Biotechs Could Lead the Next Biotech Boom 5/24/2017
6 (Plus 2!) Most Notable ASCO Abstracts So Far 5/24/2017
tranSMART Foundation Teams With IBM (IBM) to Bring Translational Medicine Data to Scientists, Merges With I2B2 5/24/2017
Biogen (BIIB) Spinoff Bioverativ (BIVV) Takes Out Bay Area's True North in $825 Million Deal 5/24/2017
Market Just Got More Crowded as Regeneron (REGN), Sanofi (SNY)'s New RA Drug Wins FDA Approval 5/24/2017
AstraZeneca PLC (AZN) Offloads Heart Drugs to Recordati in $300 Million Deal to Pump Up R&D 5/23/2017
Puma Biotech (PBYI) Surges on the FDA's Positive Breast Cancer Review 5/23/2017
Bill & Melinda Gates Foundation Bets on This Biotech to Win the Zika Race (Hint, It's a Unicorn) 5/23/2017
Amgen (AMGN) Faces Setback as Osteoporosis Drug is Linked to Serious Heart Side Effects 5/23/2017
Amazon (AMZN) Hiring to Break Into the Pharmaceuticals Business 5/23/2017
3 Biotechs Bouncing Back After a Tough 2016 5/23/2017
5 Biotechs Releasing Highly-Anticipated Data at ASCO 5/22/2017
Mayor, BIO Team up to Tout San Diego’s Life Sciences Community 5/22/2017
Novartis AG (NVS) to Shed Another 500 Jobs, Add 350 High-Tech Jobs 5/19/2017
Apple (AAPL) CEO Spotted Wearing a Prototype Glucose-Tracker on the Apple Watch 5/19/2017
Two NIH Sources Reveal President Trump is Considering New Cuts to Biomedical Research 5/19/2017
Merck & Co. (MRK)'s Immuno-Oncology Star Racks Up Two New Bladder Cancer Approvals 5/19/2017
Genentech (RHHBY) Will Pass Out More Cash to Researchers to Stand Up to Cancer 5/18/2017
Confident Johnson & Johnson (JNJ) Flexes Its Muscles, Plans 10 Blockbuster Approvals by 2021 5/18/2017
FDA Slaps Clinical Hold on Concert Pharma (CNCE)'s Hair Loss Drug 5/18/2017
Vesalius Raises €65 Million While Novartis AG (NVS) Alum's VC Seeks €50 Million to Bet on Italian Scientists 5/18/2017
Short Seller Who Unraveled Valeant (VRX) Zeroes in On This Massachusetts Biotech 5/18/2017
AstraZeneca PLC (AZN) Sues Former Exec After GlaxoSmithKline (GSK) Poaches Him Away to Run Its Largest Business 5/18/2017
Teva (TEVA) Cuts Another 500 Jobs, May Hire CEO Who Isn’t Israeli 5/18/2017
Spotted in the Bay Area: Former FDA Head in Talks to Join Google (GOOG)'s Verily (GOOGL) 5/18/2017
Former Xontogeny CEO Emerges to Helm Newly-Launched $25 Million Biotech Startup Accelerator 5/18/2017
Shire (SHPG)'s $6.5 Billion Dyax (DYAX) Bet Pays Off as Lanadelumab Wows in Phase III Study 5/18/2017
GlycoMimetics (GLYC) Stock Takes Off on Positive Phase II Leukemia Data, Breakthrough Tag 5/18/2017
Cancer Biotech G1 Therapeutics (GTHX) Grabs $105 Million in IPO 5/17/2017
Thermo Fisher Scientific (TMO) Bags Patheon (PTHN) in $7.2 Billion Deal, Pantheon Stock Soars 5/17/2017
How Merck & Co. (MRK) Could Have Lucked Into a $10 Billion Drug 5/17/2017
Why Pfizer (PFE) May Need Another Big M&A for Growth 5/17/2017
3 Rock-Bottom Biotechs That Big Market Players are Betting On 5/17/2017
New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs 5/17/2017
Braeburn Pharma Keeps Up with Competitors with Long-Acting Risperidone for Schizophrenia 5/17/2017
New FDA Head's First Order of Business: Inspection Staff Reorg and Lower Drug Prices 5/17/2017
Synlogic Takes Chance on Failed Austin Biotech, Finds Spot in the Nasdaq 5/16/2017
Biogen (BIIB)'s CSO Quietly Leaves, But Will Still Get R&D Funding From the Biotech Giant 5/16/2017
With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO 5/16/2017



//-->